Show simple item record

dc.contributor.authorJenna Hoyt, Jenny Hill, Florence Achieng, Peter Ouma, Simon Kariuki, Meghna Desai, Jayne Webster
dc.date.accessioned2022-10-13T15:55:27Z
dc.date.available2022-10-13T15:55:27Z
dc.date.issued2021
dc.identifier.urihttps://repository.maseno.ac.ke/handle/123456789/5390
dc.descriptionhttps://malariajournal.biomedcentral.com/articles/10.1186/s12936-021-03826-8en_US
dc.description.abstractIn malaria endemic regions in Kenya, pregnant women are ofered long-lasting insecticidal nets and intermittent preventive treatment (IPTp) with sulfadoxine–pyrimethamine (SP) at antenatal care (ANC) to prevent the adverse efects of malaria. Fears of growing SP resistance have heightened the search for alternative strategies. The implementation feasibility of intermittent screening and treatment (ISTp) with dihydroartemisinin–piperaquine (DP) in routine ANC settings was evaluated using qualitative and quantitative methods, including the exploration of healthcare provider and pregnant women’s perceptionsen_US
dc.publisherBioMed Centralen_US
dc.subject: Feasibility, Intermittent screening and treatment, Intermittent preventive treatment, Dihydroartemisinin– piperaquine, Health system delivery, Pregnant women, Healthcare providers, Kenyaen_US
dc.titleHealthcare provider and pregnant women’s perspectives on the implementation of intermittent screening and treatment with dihydroartemisinin–piperaquine for malaria in pregnancy in western Kenya: a qualitative studyen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record